Literature DB >> 28364918

The origins of the vaccine cold chain and a glimpse of the future.

John Lloyd1, James Cheyne2.   

Abstract

International efforts to eradicate smallpox in the 1960s and 1970s provided the foundation for efforts to expand immunization programmes, including work to develop immunization supply chains. The need to create a reliable system to keep vaccines cold during the lengthy journey from the manufacturer to the point of use, even in remote areas, was a crucial concern during the early days of the Expanded Programme on Immunization. The vaccine cold chain was deliberately separated from other medical distribution systems to assure timely access to and control of vaccines and injection materials. The story of the early development of the vaccine cold chain shows how a number of challenges were overcome with technological and human resource solutions. For example, the lack of methods to monitor exposure of vaccines to heat during transport and storage led to many innovations, including temperature-sensitive vaccine vial monitors and better methods to record and communicate temperatures in vaccine stores. The need for appropriate equipment to store and transport vaccines in tropical developing countries led to innovations in refrigeration equipment as well as the introduction and widespread adoption of novel high performance vaccine cold-boxes and carriers. New technologies also helped to make injection safer. Underlying this work on technologies and equipment was a major effort to develop the human resources required to manage and implement the immunization supply chain. This included creating foundational policies and a management infrastructure; providing training for managers, health workers, technicians, and others. The vaccine cold chain has contributed to one of the world's public health success stories and provides three priority lessons for future: the vaccine supply chain needs to be integrated with other public health supplies, re-designed for efficiency and effectiveness and work is needed in the longer term to eliminate the need for refrigeration in the supply chain.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Cold chain; Equipment; Expanded Programme on Immunization; Immunization; Programme management; Vaccines

Mesh:

Substances:

Year:  2017        PMID: 28364918     DOI: 10.1016/j.vaccine.2016.11.097

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.

Authors:  Mario Amacker; Charli Smardon; Laura Mason; Jack Sorrell; Kirk Jeffery; Michael Adler; Farien Bhoelan; Olga Belova; Mark Spengler; Beena Punnamoottil; Markus Schwaller; Olivia Bonduelle; Behazine Combadière; Toon Stegmann; Andrew Naylor; Richard Johnson; Desmond Wong; Sylvain Fleury
Journal:  NPJ Vaccines       Date:  2020-05-18       Impact factor: 7.344

2.  Evaluation of growth and sporulation of a non-toxigenic strain of Clostridioides difficile (Z31) and its shelf viability.

Authors:  Carlos Augusto Oliveira Júnior; Rodrigo Otávio Silveira Silva; Diogo Soares Gonçalves Cruz; Isadora Honorato Pires; Guilherme Guerra Alves; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2018-12-18       Impact factor: 2.476

3.  A two-stage decision-support approach for improving sustainable last-mile cold chain logistics operations of COVID-19 vaccines.

Authors:  Eugenia Ama Andoh; Hao Yu
Journal:  Ann Oper Res       Date:  2022-08-21       Impact factor: 4.820

4.  Marked Atrophic Changes of the Brain in a Patient with Subacute Sclerosing Panencephalitis.

Authors:  Faizan Yasin; Salman Assad; Muhammad Nadeem; Mehr Zahid
Journal:  Cureus       Date:  2017-08-21

Review 5.  Antibodies, synthetic peptides and related constructs for planetary health based on green chemistry in the Anthropocene.

Authors:  Salvador Eugenio Caoili
Journal:  Future Sci OA       Date:  2018-01-10

Review 6.  Chikungunya Virus Vaccines: Platforms, Progress, and Challenges.

Authors:  Victor R DeFilippis
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.291

7.  Good vaccination practice: it all starts with a good vaccine storage temperature.

Authors:  Frédéric Vangroenweghe
Journal:  Porcine Health Manag       Date:  2017-12-04

Review 8.  Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.

Authors:  Nicola Luigi Bragazzi; Vincenza Gianfredi; Milena Villarini; Roberto Rosselli; Ahmed Nasr; Amr Hussein; Mariano Martini; Masoud Behzadifar
Journal:  Front Public Health       Date:  2018-03-05

9.  New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes.

Authors:  Mario Amacker; Charli Smardon; Laura Mason; Jack Sorrell; Kirk Jeffery; Michael Adler; Farien Bhoelan; Olga Belova; Mark Spengler; Beena Punnamoottil; Markus Schwaller; Olivia Bonduelle; Behazine Combadière; Toon Stegmann; Andrew Naylor; Richard Johnson; Desmond Wong; Sylvain Fleury
Journal:  NPJ Vaccines       Date:  2020-05-18       Impact factor: 7.344

10.  Knowledge, perception and practice towards oxytocin stability and quality: A qualitative study of stakeholders in three resource-limited countries.

Authors:  Victoria L Oliver; Peter A Lambert; Kyu Kyu Than; Yasmin Mohamed; Stanley Luchters; Snigdha Verma; Ranjana Yadav; Vishwajeet Kumar; Alula M Teklu; Moti Tolera; Abebaw Minaye; Michelle P McIntosh
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.